Halberd/Athena GTX Research Promises a Much Brighter Future pr-inside.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pr-inside.com Daily Mail and Mail on Sunday newspapers.
People with both Type 1 and Type 2 diabetes often experience suppressed wound healing. Penn State research-based startup ElkosRx is working to bring its topical treatment for early-stage diabetic foot ulcers to the market.
Left to right: Patricia McLaughlin, Dr. Joseph Sassani and Ian Zagon.
Image: Penn State College of Medicine
Researchers receive grant to continue developing diabetic foot ulcers treatment
April 21, 2021
HERSHEY, Pa. A research team from Penn State College of Medicine will use a $200,000 grant to further develop a topically applied therapy for the treatment of diabetic foot ulcers. Researchers hope it will be a safer, more effective and less expensive treatment option for more than four million diabetic patients in the U.S. who have this condition, which if left untreated, may require amputation.
Patricia McLaughlin, professor of neural and behavioral sciences, leads the research team which includes co-investigators Dr. Joseph Sassani, professor and vice chair for clinical affairs in the Department of Ophthalmology and professor of pathology and laboratory medicine, and Ian Zagon, distinguished professor of neural and behavioral sciences.